Thomas Barnes, Louis Tartaglia

Premium
Gene Logic has promoted Thomas Barnes to senior vice president of discovery, a position that will put him in charge of drug repositioning, the company said this week.
 
Barnes will take over the position from Louis Tartaglia, who is resigning from the job to become a partner in a venture capital firm.
 
Barnes formerly was co-founder of the drug repositioning initiative at Millennium Pharmaceuticals, which Gene Logic purchased from Millennium in 2004.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.